Literature DB >> 9288831

Loss of inhibitory synapses on the soma and axon initial segment of pyramidal cells in human epileptic peritumoural neocortex: implications for epilepsy.

P Marco1, R G Sola, S Ramón y Cajal, J DeFelipe.   

Abstract

The peritumoural neocortex removed from epileptic patients represents an important region for research because of its possible relationship to the generation, maintenance, and propagation of seizures. The peritumoural neocortex removed from an epileptic patient showing a regrowth of an anaplastic astrocytoma was examined in detail using immunocytochemistry for gamma-aminobutyric acid, glutamic acid decarboxylase, parvalbumin, nonphosphorylated neurofilament protein, glial fibrillary acidic protein, and histocompatibility antigen HLA-DR. The patterns of immunostaining were compared with the cytoarchitecture and myeloarchitecture in adjacent sections, and with the patterns of immunostaining observed in normal control neocortex. Furthermore, quantitative electron microscopy was used to compare the synaptic densities of presumptive excitatory and inhibitory synapses between regions showing different grades of cytoarchitectural and neurochemical alterations in the peritumoural neocortex, and to compare these regions with normal neocortex. A variety of changes in synaptic circuits in the peritumoural neocortex was found, but it appears that neurons within the less abnormal-looking regions were involved in altered synaptic circuits that might contribute to epileptic activity. In these regions, the most prominent change was the loss of inhibitory synapses on the soma and axon initial segment of pyramidal cells, but numerous excitatory synapses were present on their dendrites that would make these neurons hyperexcitable. However, the most abnormal regions histologically were likely a primary zone for progression of the tumour, with many surviving neurones, but which received and formed very few synapses; thus, they were probably unrelated to the initiation, maintenance, or propagation of seizures.

Entities:  

Mesh:

Year:  1997        PMID: 9288831     DOI: 10.1016/s0361-9230(97)00090-7

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  15 in total

1.  Epileptic seizures from abnormal networks: why some seizures defy predictability.

Authors:  William S Anderson; Feraz Azhar; Pawel Kudela; Gregory K Bergey; Piotr J Franaszczuk
Journal:  Epilepsy Res       Date:  2011-12-12       Impact factor: 3.045

Review 2.  Shedding Light on Chandelier Cell Development, Connectivity, and Contribution to Neural Disorders.

Authors:  Nicholas B Gallo; Anirban Paul; Linda Van Aelst
Journal:  Trends Neurosci       Date:  2020-06-18       Impact factor: 13.837

3.  Brain microglial cytokines in neurogenic hypertension.

Authors:  Peng Shi; Carlos Diez-Freire; Joo Yun Jun; Yanfei Qi; Michael J Katovich; Qiuhong Li; Srinivas Sriramula; Joseph Francis; Colin Sumners; Mohan K Raizada
Journal:  Hypertension       Date:  2010-06-14       Impact factor: 10.190

Review 4.  Seizures and gliomas--towards a single therapeutic approach.

Authors:  Gilles Huberfeld; Charles J Vecht
Journal:  Nat Rev Neurol       Date:  2016-03-11       Impact factor: 42.937

5.  Development of NMDA NR2 subunits and their roles in critical period maturation of neocortical GABAergic interneurons.

Authors:  Zhi Zhang; Qian-Quan Sun
Journal:  Dev Neurobiol       Date:  2011-03       Impact factor: 3.964

6.  Functional alterations in GABAergic fast-spiking interneurons in chronically injured epileptogenic neocortex.

Authors:  Yunyong Ma; David A Prince
Journal:  Neurobiol Dis       Date:  2012-03-29       Impact factor: 5.996

7.  Manipulating critical period closure across different sectors of the primary auditory cortex.

Authors:  Etienne de Villers-Sidani; Kimberly L Simpson; Y-F Lu; Rick C S Lin; Michael M Merzenich
Journal:  Nat Neurosci       Date:  2008-07-06       Impact factor: 24.884

Review 8.  Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy.

Authors:  Terri S Armstrong; Robin Grant; Mark R Gilbert; Jong Woo Lee; Andrew D Norden
Journal:  Neuro Oncol       Date:  2015-11-02       Impact factor: 12.300

Review 9.  Building and maintaining the axon initial segment.

Authors:  Matthew S Grubb; Juan Burrone
Journal:  Curr Opin Neurobiol       Date:  2010-05-27       Impact factor: 6.627

10.  Chronic α1-Na/K-ATPase inhibition reverses the elongation of the axon initial segment of the hippocampal CA1 pyramidal neurons in Angelman syndrome model mice.

Authors:  Prudhvi Raj Rayi; Alexei Y Bagrov; Hanoch Kaphzan
Journal:  Neuropsychopharmacology       Date:  2020-11-19       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.